News

Gary Lowenthal Joins Focused Ultrasound Foundation’s Council

The Focused Ultrasound Foundation is pleased to welcome Gary Lowenthal to its Council, a dedicated group of goodwill ambassadors who work closely with the Board of Directors and staff to provide advice and assist with raising funds and building awareness.

Mr. Lowenthal is a retired educator, entrepreneur, and executive with a career spanning education, international service, and business leadership.

He began his professional journey as a teacher serving in the Peace Corps, teaching in underserved communities in Fiji. Upon returning to the US, he held an executive position at Bloomingdale’s before founding The Boyds Collection Ltd. in 1979, a company that became a leader in the plush and figurine market renowned for its lovingly crafted handmade collectibles. As “the Head Bean Hisself,” he personally designed much of the original Boyds Bears lineup, infusing each piece with his sense of humor, warmth, and a clear eye for character.

In addition to his business ventures, Mr. Lowenthal remained dedicated to education and taught entrepreneurship to budding innovators at Mount St. Mary’s University.

“Gary’s unique blend of creativity, entrepreneurial spirit, and dedication to service makes him a tremendous asset to the Foundation’s Council,” said Foundation Chairman Neal F. Kassell, MD. “His insight and energy will strengthen our efforts to advance this transformative technology and expand its access to patients.”

“It’s an honor to join the Foundation’s Council and support such groundbreaking work,” Mr. Lowenthal said. “I’m inspired by the potential of focused ultrasound to revolutionize medicine, and I look forward to contributing to a mission that has real, lasting impact on people’s lives.”

Born and raised in New York City, Mr. Lowenthal earned a bachelor of science degree in biology and a master’s degree in biology and education from Alfred University.

Read more here.

Recent News

09/01/2026

Andre Marshall to join National Science Foundation; Aurali Dade named Interim Vice President for Research, Innovation, and Economic Impact

Since joining George Mason in 2021, Marshall has played a pivotal role in advancing the university’s research enterprise and entrepreneurial ecosystem and strengthening the university’s reputation as a leading public R1 institution, including launching the Grand Challenge Initiative and empowering institute-driven initiatives like Nexus234 and the Virginia Climate Center. During Marshall’s tenure, George Mason expanded research activity and strategic partnerships,

08/25/2026

United Therapeutics Corporation Announces FDA Filing Acceptance of New Drug Application for Ralinepag to Treat Pulmonary Arterial Hypertension

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the FDA has accepted the New Drug Application (NDA) for ralinepag to treat PAH. The FDA has set a Prescription Drug User Fee Act target action date of June 24, 2027. Ralinepag has not been approved for use in any indication by the

08/19/2026

ATCC Receives New CDC Award to Advance Influenza Testing and Surveillance

ATCC has been selected by the Centers for Disease Control and Prevention (CDC) for a new contract to support serological assays for the detection and characterization of influenza viruses. The award, valued at up to $7.3 million over the 5-year contract period (contract 75D30126C21030), will support CDC’s National Center for Immunization and Respiratory Diseases, Influenza